Tomorrow's pharmacist blog
All posts from: January 2013
A lot flashes through my mind on a daily basis. This can actually be quite frustrating as I consider all sorts of, what would appear to be, nonsense. However, a lot of what I think about actually isn’t... Anyway, down to business.
So, guess what I learned today? That it is becoming more and more possible to treat cancer with a vaccine. Sounds weird, doesn’t it? But it’s true!
HER2 is a protein which is found on the surface of some cancer cells and is linked with breast cancer. Some people with breast cancer over express HER2 and in these cases, the tumour is said to be HER2 positive. HER2 positive breast cancers have been shown to grow quicker than other types of breast cancer and therefore have a higher rate of metastasis and mortality.
Think histamine and you think of allergy and stomach acid, right? Well, as it turns out, this is only part of the picture. There are three types of histamine receptors; H1, H2 and H3. H1 has its main role in allergy and is the main target for traditional pharmacological antihistamines used in the treatment of allergic conditions. H2 is the target for drugs such as ranitidine and cimetidine
It has been well established that obesity predisposes a person to a multitude of other health problems, commonly including type 2 diabetes, hypertension, stroke, MI, the list goes on. But there is strong evidence that visceral fat, causing central obesity, is directly responsible for secreting adipokines and cytokines.
Cachexia is the wasting of muscle that cannot be reversed by nutrition and is normally associated with a poor prognosis. This is commonly seen in those patients with cancer, along with a number of other conditions. This weakens the patients, opening them up to number of complications and reducing the likelihood of them responding to treatment.